Collective effort to address a challenge to health, food security, and development

World leaders today signalled an unprecedented level of attention to curb the spread of infections that are resistant to antimicrobial medicines.

Antimicrobial resistance (AMR) happens when bacteria, viruses, parasites, and fungi develop resistance against medicines that were previously able to cure them.

For the first time, Heads of State committed to taking a broad, coordinated approach to address the root causes of AMR across multiple sectors, especially human health, animal health and agriculture. This is only the fourth time a health issue has been taken up by the UN General Assembly (the others were HIV, noncommunicable diseases, and Ebola).

The high-level meeting was convened by the President of the 71st session of the UN General Assembly, H.E. Peter Thomson.

'Antimicrobial resistance threatens the achievement of the Sustainable Development Goals and requires a global response,' Mr. Thomson said. 'Member States have today agreed upon a strong political declaration that provides a good basis for the international community to move forward. No one country, sector or organization can address this issue alone.'

They pledged to strengthen regulation of antimicrobials, improve knowledge and awareness, and promote best practices — as well as to foster innovative approaches using alternatives to antimicrobials and new technologies for diagnosis and vaccines.

'Antimicrobial resistance poses a fundamental threat to human health, development, and security. The commitments made today must now be translated into swift, effective, lifesaving actions across the human, animal and environmental health sectors. We are running out of time,' said Dr Margaret Chan, Director-General of WHO.

Common and life-threatening infections like pneumonia, gonorrhoea, and post-operative infections, as well as HIV, tuberculosis and malaria are increasingly becoming untreatable because of AMR. Left unchecked, AMR is predicted to have significant social, health security, and economic repercussions that will seriously undermine the development of countries.

The high levels of AMR already seen in the world today are the result of overuse and misuse of antibiotics and other antimicrobials in humans, animals (including farmed fish), and crops, as well as the spread of residues of these medicines in soil, crops and water. Within the broader context of AMR, resistance to antibiotics is considered the greatest and most urgent global risk requiring international and national attention.

'AMR is a problem not just in our hospitals, but on our farms and in our food, too. Agriculture must shoulder its share of responsibility, both by using antimicrobials more responsibly and by cutting down on the need to use them, through good farm hygiene,' said Dr José Graziano da Silva, Director-General of FAO.

'Effective and accessible antibiotics are as vital for protecting animal health and welfare and good veterinary medicine as they are for human health. We urge national authorities to strongly support all sectors involved, through promotion of responsible and prudent use, good practices and implementation of established standards and guidelines,' said Dr Monique Eloit, Director-General of OIE.

Leaders at the UN meeting called on WHO, FAO and OIE, in collaboration with development banks such the World Bank other relevant stakeholders, to coordinate their planning and actions and to report back to the UN General Assembly in September 2018.

Countries called for better use of existing, cost-effective tools for preventing infections in humans and animals. These include immunization, safe water and sanitation, and good hygiene in hospitals and animal husbandry. Putting in place systems to ensure more appropriate use of existing and new antibiotics is also essential.

In addition, they highlighted market failures, and called for new incentives for investment in research and development of new, effective and affordable medicines, rapid diagnostic tests, and other important therapies to replace those that are losing their power.

They stressed that affordability and access to existing and new antibiotics, vaccines and other medical tools should be a global priority and should take into account the needs of all countries.

Most popular related searches

Related news

Tana has developed a new heavy duty rotor for TANA Shark shredders.Wearing resistance of the rotor has been improved by Chrome-Carbide coating which has 10x better wearing resistance than standard materials used. The new rotor was tested in the UK by an experienced TANA user and they were very happy with the results.
”The shredder has been much easier tomanage from both performance and wear, the impact on the rotorknives and counter knives has significantly reduced. Material hasalso been found to be much...

ELITechGroup Molecular Diagnostics announce today the CE-IVD marking of the CRE ELITe MGB kit, a high-performance, qualitative, multiplex assay for the rapid detection of the Carbapenem Resistance genes of Enterobacteriaceae. In combination with the ELITe InGenius™, the ELITech Group’s fully automated sample-to-result system, the assay is intended to detect 150 variants belonging to the 5 main families of Carbapenem-Resistant genes: KPC, NDM, VIM, IMP, and OXA-48 like and differentiate the main...

Among the most clinically significant multidrug-resistant bacteria are carbapenemase-producing Enterobacteriaceae. Because these bacteria usually remain susceptible to polymyxins, interest in this old class of antibiotics has been recently renewed. However, the increasing use of colistin explains why Enterobacterial strains resistant to colistin are increasingly reported worldwide.
Currently available polymyxins susceptibility methods are fastidious, time-consuming (24 hours) and some methods are not reliable....

Among the most clinically significant multidrug-resistantbacteria are carbapenemase-producing Enterobacteriaceae. Because these bacteria usuallyremain susceptible to polymyxins, interest in this old class of antibiotics has been recentlyrenewed. However, the increasing use of colistin explains why Enterobacterial strains resistantto colistin are increasingly reported worldwide.Currently available polymyxins susceptibility methods are fastidious, time-consuming (24 hours) and some methods are not reliable. They...

Today, the IAQ Video Network and Cochrane & Associates announced the release of their latest educational video. Their newest production discusses a list of the biggest drug-resistant microbial threats published by the Centers for Disease Control and Prevention (CDC) in 2013.
“Some people are at greater risk than others of superbug infections, but no one can completely avoid the risk,” said Paul Cochrane, President of Cochrane and Associates and the IAQ Video Network. “We hope this new video...

Customer comments

No comments were found for At UN, global leaders commit to act on antimicrobial resistance. Be the first to comment!